Literature DB >> 31233206

Compulsions in Prader-Willi syndrome: occurrence and severity as a function of genetic subtype.

Ramon Novell-Alsina1, Susanna Esteba-Castillo1, Asumpta Caixàs2, Elisabeth Gabau3, Olga Giménez-Palop2, Jesus Pujol4, Joan Deus5, David Torrents-Rodas6.   

Abstract

INTRODUCTION: Compulsions are among the most typical behaviors in Prader-Willi syndrome (PWS). The most frequent causes of PWS are deletion of the genes located in the segment 15q11-q13 of the paternal allele and maternal uniparental disomy of cromosome 15. The aim of the present work was to study compulsive behavior in a sample of adults with PWS and analyze potential differences as a function of the genetic cause/subtype.
MATERIAL AND METHODS: In the 27 study participants, existence of type I deletion (n=7), type II deletion (n=13), and maternal disomy (n=7) was determined by means of genetic tests. The Yale-Brown Obsessive Compulsive Scale, the Compulsive Behavior Checklist, and the Repetitive Behavior Questionnaire were used to assess occurrence and severity of compulsions.
RESULTS: Most of the participants showed compulsive behavior, the most frequent compulsions were those of inappropriate grooming (skin picking) and order (hoarding). The occurrence of compulsions was less frequent in the maternal disomy group than in the deletion groups. Severe compulsions were more frequent in those participants with type II deletion than in the other groups.
CONCLUSIONS: Differences in occurrence and severity of compulsions exist as a function of PWS genetic subtype. Our results support the idea that individuals with maternal disomy are less affected by compulsive behavior. More research on the severity of compulsions as a function of deletion type should be done, as the studies conducted so far have shown contradictory results.

Entities:  

Year:  2019        PMID: 31233206

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  7 in total

1.  Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome.

Authors:  Janice Forster; Jessica Duis; Merlin G Butler
Journal:  Genes (Basel)       Date:  2021-01-24       Impact factor: 4.096

2.  Food and Non-Food-Related Behavior across Settings in Children with Prader-Willi Syndrome.

Authors:  Marie G Gantz; Sara M Andrews; Anne C Wheeler
Journal:  Genes (Basel)       Date:  2020-02-17       Impact factor: 4.096

3.  Social Responsiveness and Psychosocial Functioning in Adults with Prader-Willi Syndrome.

Authors:  Meritxell Fernández-Lafitte; Jesus Cobo; Ramon Coronas; Isabel Parra; Joan Carles Oliva; Aida Àlvarez; Susanna Esteba-Castillo; Olga Giménez-Palop; Diego J Palao; Assumpta Caixàs
Journal:  J Clin Med       Date:  2022-03-05       Impact factor: 4.241

4.  One Year of Recombinant Human Growth Hormone Treatment in Adults with Prader-Willi Syndrome Improves Body Composition, Motor Skills and Brain Functional Activity in the Cerebellum.

Authors:  Laia Casamitjana; Laura Blanco-Hinojo; Olga Giménez-Palop; Jesús Pujol; Gerard Martínez-Vilavella; Susanna Esteba-Castillo; Rocío Pareja; Valentín Freijo; Laura Vigil; Joan Deus; Assumpta Caixàs
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

5.  Health Problems in Adults with Prader-Willi Syndrome of Different Genetic Subtypes: Cohort Study, Meta-Analysis and Review of the Literature.

Authors:  Anna G W Rosenberg; Charlotte M Wellink; Juan M Tellez Garcia; Karlijn Pellikaan; Denise H Van Abswoude; Kirsten Davidse; Laura J C M Van Zutven; Hennie T Brüggenwirth; James L Resnick; Aart J Van der Lely; Laura C G De Graaff
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

Review 6.  Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium.

Authors:  Lauren Schwartz; Assumpta Caixàs; Anastasia Dimitropoulos; Elisabeth Dykens; Jessica Duis; Stewart Einfeld; Louise Gallagher; Anthony Holland; Lauren Rice; Elizabeth Roof; Parisa Salehi; Theresa Strong; Bonnie Taylor; Kate Woodcock
Journal:  J Neurodev Disord       Date:  2021-06-21       Impact factor: 4.025

7.  Multidimensional Evaluation of Awareness in Prader-Willi Syndrome.

Authors:  Jesús Cobo; Ramón Coronas; Esther Pousa; Joan-Carles Oliva; Olga Giménez-Palop; Susanna Esteba-Castillo; Ramon Novell; Diego J Palao; Assumpta Caixàs
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.